Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYX NASDAQ:HYPR NASDAQ:NVNO OTCMKTS:UEEC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$2.12-9.8%$2.08$0.76▼$2.73$88.88M1.39101,503 shs146,235 shsHYPRHyperfine$1.45+14.2%$0.91$0.53▼$1.90$98.85M1.06565,829 shs2.17 million shsNVNOenVVeno Medical$4.50-1.7%$4.45$2.03▼$5.70$88.15M1.01165,476 shs282,965 shsUEECUnited Health Products$0.09+1.2%$0.10$0.05▼$0.28$21.90M-1.56165,430 shs31,802 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-9.79%+8.16%+3.41%+48.25%+79.66%HYPRHyperfine+14.17%+26.09%+80.12%+133.38%+38.10%NVNOenVVeno Medical-1.75%-5.06%+8.96%+24.31%-13.63%UEECUnited Health Products+1.17%+7.88%-13.79%-63.46%-46.06%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical1.7873 of 5 stars0.03.00.04.22.41.70.6HYPRHyperfine1.8716 of 5 stars1.35.00.00.03.02.50.6NVNOenVVeno Medical0.8623 of 5 stars0.02.00.00.03.90.80.6UEECUnited Health Products0.235 of 5 stars0.05.00.00.00.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/AHYPRHyperfine 2.67Moderate Buy$1.23-15.40% DownsideNVNOenVVeno Medical 0.00N/AN/AN/AUEECUnited Health Products 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest UEEC, HYPR, NVNO, and APYX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/14/2025HYPRHyperfineLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$1.50 ➝ $2.006/3/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/15/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$1.20 ➝ $1.00(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M1.67N/AN/A$0.20 per share10.60HYPRHyperfine$12.89M8.76N/AN/A$0.67 per share2.16NVNOenVVeno MedicalN/AN/AN/AN/A$1.72 per shareN/AUEECUnited Health Products$40K553.96N/AN/A($0.01) per share-8.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$23.46M-$0.45N/AN/AN/A-37.11%-158.22%-28.30%N/AHYPRHyperfine-$40.72M-$0.54N/AN/AN/A-364.54%-78.47%-65.00%N/ANVNOenVVeno Medical-$21.82M-$1.20N/AN/AN/AN/A-57.35%-53.49%10/29/2025 (Estimated)UEECUnited Health Products-$2M-$0.02N/A∞N/AN/AN/A-1,905.82%N/ALatest UEEC, HYPR, NVNO, and APYX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025HYPRHyperfine-$0.12-$0.12N/A-$0.12$3.00 million$2.70 million8/7/2025Q2 2025APYXApyx Medical-$0.0933-$0.09+$0.0033-$0.09$11.69 million$11.37 million7/31/2025Q2 2025NVNOenVVeno Medical-$0.28-$0.33-$0.05-$0.33N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/ANVNOenVVeno MedicalN/AN/AN/AN/AN/AUEECUnited Health ProductsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical4.614.723.95HYPRHyperfineN/A6.075.48NVNOenVVeno MedicalN/A11.8111.81UEECUnited Health ProductsN/A0.020.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%HYPRHyperfine15.03%NVNOenVVeno Medical34.71%UEECUnited Health Products0.07%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical15.20%HYPRHyperfine30.98%NVNOenVVeno Medical16.00%UEECUnited Health Products1.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.82 million32.07 millionOptionableHYPRHyperfine19077.83 million53.72 millionOptionableNVNOenVVeno Medical3019.25 million16.17 millionOptionableUEECUnited Health Products4256.76 million252.91 millionNot OptionableUEEC, HYPR, NVNO, and APYX HeadlinesRecent News About These CompaniesUnited Health Products Provides Regulatory Application UpdateJune 6, 2025 | finance.yahoo.comUnited Health Products Announces OTCQB Uplisting and FDA UpdateMay 1, 2025 | finance.yahoo.comUnited Health Products Provides Update on FDA and OTC Markets ApplicationsMarch 28, 2025 | finance.yahoo.comUnited Health Products Provides Update on Capital Markets and Regulatory ProcessesMarch 14, 2025 | finance.yahoo.comUnited Health Products Provides Update on Clinical Study ProcessDecember 2, 2024 | globenewswire.com2 recalls impacting Lubbock area supermarkets, including H-E-B, Walmart, UnitedOctober 31, 2024 | yahoo.comUnited Laboratories’ Antibiotic Product Gains Key ApprovalOctober 26, 2024 | msn.comEco Bandage, Greener Living Products receive ECRM Health Care Buyers’ Choice AwardsOctober 14, 2024 | drugstorenews.comDUnited overhauls economy-class wine menu with 4 new optionsOctober 1, 2024 | thepointsguy.comTUnited Supermarkets Partners on New Health Care BenefitSeptember 30, 2024 | progressivegrocer.comPRising Extreme Heat Compounds the U.S. Maternal Health CrisisSeptember 30, 2024 | americanprogress.orgAUnited Healthcare cuts UF Health from in-provider networkSeptember 5, 2024 | mainstreetdailynews.comMUnited Therapeutics: Strong Buy Rating on FDA Exclusivity and Market Dominance for Tyvaso DPIAugust 20, 2024 | markets.businessinsider.comUnited Health Products Submits Response Letter to FDAAugust 19, 2024 | globenewswire.comFDA warns producer about lead levels in its apple cinnamon puree productsAugust 17, 2024 | msn.comUnitedHealthcare: Health care coverage and benefitsAugust 14, 2024 | unitedhealthgroup.comUHealth Headlines: How to spot ultra-processed foodsAugust 13, 2024 | msn.comUnited Health Products Inc.May 25, 2024 | wsj.comStudy finds front-of-package nutrition labeling results in healthier productsMay 15, 2024 | msn.comHealth risks of ultra-processed foods revealed in 30-year studyMay 10, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUEEC, HYPR, NVNO, and APYX Company DescriptionsApyx Medical NASDAQ:APYX$2.12 -0.23 (-9.79%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$2.12 +0.00 (+0.24%) As of 08/14/2025 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.Hyperfine NASDAQ:HYPR$1.45 +0.18 (+14.17%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$1.46 +0.01 (+0.69%) As of 05:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.enVVeno Medical NASDAQ:NVNO$4.50 -0.08 (-1.75%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$4.51 +0.01 (+0.20%) As of 08/14/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial. United Health Products OTCMKTS:UEEC$0.09 +0.00 (+1.17%) As of 08/14/2025 03:53 PM EasternUnited Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers HemoStyp hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. United Health Products, Inc. was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Deere’s Sell-Off Could Be a Long-Term Buying Chance Cisco Systems: The Only AI Stock Income Investors Need to Own Gartner’s RSI Just Sank to 11: That’s a Setup You Can’t Ignore How Did Peter Thiel-Backed Crypto Exchange Bullish's IPO Go? Mercury Systems Up 27%: Financials Send Investors a Clear Signal Brinker Serves Up Earnings Beat, Sidesteps Cost Pressures CAVA’s Honeymoon Ends With a 16% Stock Drop Rigetti Stock: A Long-Term Quantum Play Facing Short-Term Tests Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access